Filing Details

Accession Number:
0000905148-19-000666
Form Type:
13D Filing
Publication Date:
2019-07-02 16:35:40
Filed By:
Schuler Jack W
Company:
Aspira Women's Health Inc. (NASDAQ:AWH)
Filing Date:
2019-07-02
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Jack W. Schuler 0 23,108,802 0 23,108,802 23,108,802 24.3%
Jack W. Schuler Living Trust 0 23,108,802 0 23,108,802 23,108,802 24.3%
Filing


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
                                                                                                                                                                                        

 
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 10)*
 
VERMILLION, INC.
 (Name of Issuer)
 
Common Stock, Par Value $0.001 Per Share
 (Title of Class of Securities)
 
92407M206
 (CUSIP Number)
 
Jack W. Schuler
100 N. Field Drive, Suite 360
Lake Forest, Illinois 60045
(224) 880-1211
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

June 28, 2019
(Date of Event which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [  ]
 
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See Rule 13d-7 for other parties to whom copies are to be sent.
 
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
SCHEDULE 13D
 
 
 
 
CUSIP No: 92407M206
 
Page 2 of 6 Pages

1
NAMES OF REPORTING PERSONS
 
 
Jack W. Schuler
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
PF
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
United States
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
0
 
 
 
 
8
SHARED VOTING POWER
 
 
23,108,802 (1)
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
0
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
23,108,802 (1)
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
23,108,802 (1)
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
24.3%
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
IN
 
 
 
 

 
1.  This amount includes 730,560 Shares (as defined herein) that may be acquired upon exercise of Warrants (as defined in Amendment No. 8).
 
 
SCHEDULE 13D
 
 
 
 
CUSIP No: 92407M206
 
Page 3 of 6 Pages

1
NAMES OF REPORTING PERSONS
 
 
Jack W. Schuler Living Trust
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
WC
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Illinois
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
0
 
 
 
 
8
SHARED VOTING POWER
 
 
23,108,802 (1)
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
0
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
23,108,802 (1)
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
23,108,802 (1)
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
24.3%
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 

1.  This amount includes 730,560 Shares (as defined herein) that may be acquired upon exercise of Warrants (as defined in Amendment No. 8).
 
 
 
SCHEDULE 13D
 
 
 
 
 
 
Page 4 of 6 Pages
 
Item 1.
Security and Issuer

This Amendment No. 10 to Schedule 13D (“Amendment No. 10”) is being filed by the undersigned, pursuant to §240.13d-2(a), to amend and supplement the Schedule 13D filed on May 23, 2013, (the “Initial Schedule 13D”), as amended by Amendment No. 1 filed on December 29, 2014, Amendment No. 2 filed on February 11, 2015, Amendment No. 3 filed on March 23, 2015, Amendment No. 4 filed on April 28, 2015, Amendment No. 5 filed on July 21, 2015, Amendment No. 6 filed on February 2, 2017, and Amendment No. 7 filed on September 5, 2017, Amendment No. 8 filed on April 19, 2018, and Amendment No. 9 filed on June 25, 2018 (collectively, the “Schedule 13D”), with respect to the common stock, par value $0.001 per share (the “Shares”), of Vermillion, Inc. (the “Issuer”), whose principal executive offices are located at 12117 Bee Caves Road, Building Three, Suite 100, Austin, Texas 78738.

Item 3.
Source and Amount of Funds or Other Consideration

Item 3 of the Schedule 13D is hereby amended and supplemented as follows:

A total of $4,000,000 was paid to acquire the 5,000,000 Shares acquired by Mr. Schuler in connection with the June 2019 Offering (defined and described in Item 4 herein), representing a price of $0.80 per Share.  The funds used to make these purchases were personal funds of Mr. Schuler.

Item 4.
Purpose of Transaction

Item 4 of the Schedule 13D is hereby amended and supplemented as follows:

On June 25, 2019, the Issuer announced the pricing of an underwritten public offering of 18,750,000 Shares at a price of $0.80 per Share, plus a 30-day option for the underwriter to purchase up to an additional 2,812,500 Shares at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any (the “June 2019 Offering”).  The June 2019 Offering closed on June 28, 2018.

 Pursuant to certain participation rights granted in the Stockholders Agreement related to a private placement of Shares in May 2013 and previously described in the Initial Schedule 13D and Amendment No. 2, Mr. Schuler has the right to participate in any future offerings of the Issuer’s equity securities, including the June 2019 Offering, at the same price and on the same terms as such securities are offered to other investors, subject to certain limitations and exceptions.  

In connection with the closing of the June 2019 Offering, Mr. Schuler acquired 5,000,000 Shares. 

Item 5.
Interest in Securities of the Issuer
 
Item 5 of the Schedule 13D is hereby amended and supplemented as follows:

(a, b)  As of the date hereof, each of Mr. Schuler and the Living Trust may be deemed to beneficially own 23,108,802 Shares, representing approximately 24.3% of the Shares outstanding.  This amount consists of:  (i) 22,378,242 Shares held by the Living Trust; and (ii) Warrants to acquire 730,560 Shares held by the Living Trust.

The foregoing percentages of Shares outstanding are based on a Shares outstanding figure that reflects the sum of:  (i) the 75,628,200 Shares outstanding as of June 25, 2019, as disclosed in the

 
SCHEDULE 13D
 
 
 
 
 
 
Page 5 of 6 Pages
 
Issuer’s prospectus on Form 424B5, filed on June 27, 2019; (ii) the 18,750,000 Shares issued in connection with the June 2019 Offering; and (iii) for purposes of calculating beneficial ownership pursuant to Rule 13d-3(d)(1)(i) under the Exchange Act, the 730,560 Shares issuable upon exercise of the Warrants held by the Living Trust.

As sole trustee of the Living Trust, Mr. Schuler and the Living Trust share the power to vote or to direct the vote, and the power to dispose or to direct the disposition of, the Shares and Warrants held by the Living Trust.

(c) Other than the purchases in the June 2019 Offering as described in Item 3 and Item 4 of this Amendment No. 10, no transactions in the Shares have been effected by the Reporting Persons within the past 60 days.

 (d) Except as set forth in this Schedule 13D, to the knowledge of the Reporting Persons, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares covered by the Schedule 13D.

(e) Not applicable.



 
SCHEDULE 13D
 
 
 
 
 
 
Page 6 of 6 Pages
 
SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

      Jack W. Schuler  
 
   
/s/ Jack W. Schuler
 

      Jack W. Schuler Living Trust  
      /s/ Jack W. Schuler  
 
   
Name:     Jack W. Schuler
 
      Title:       Trustee  
 

 
 
 


July 2, 2019

Attention: Intentional misstatements or omissions of act constitute federal violations (see 18 U.S.C. 1001).